Fitzgerald Kevin Joseph
81 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-07 | OVID | Ovid Therapeutics Inc. | Award | 17,578 | $2.56 | $44,999.68 | filing |
| 2026-03-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 233 | $323.25 | $75,317.25 | filing |
| 2026-03-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 153 | $326.24 | $49,914.72 | filing |
| 2026-03-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 148 | $324.60 | $48,040.80 | filing |
| 2026-03-05 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 124 | $321.81 | $39,904.44 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 210 | $323.84 | $68,006.40 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 96 | $323.01 | $31,008.96 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 79 | $321.82 | $25,423.78 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 75 | $324.88 | $24,366.00 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 59 | $320.81 | $18,927.79 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 57 | $325.67 | $18,563.19 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 29 | $319.03 | $9,251.87 | filing |
| 2026-03-04 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 28 | $320.01 | $8,960.28 | filing |
| 2026-02-23 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 158 | $0.00 | $0.00 | filing |
| 2026-02-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 2,041 | $331.96 | $677,531.58 | filing |
| 2026-02-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,959 | $310.08 | $607,448.29 | filing |
| 2026-02-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 4,000 | $0.00 | $0.00 | filing |
| 2026-01-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 644 | $370.00 | $238,280.00 | filing |
| 2026-01-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 562 | $368.76 | $207,243.12 | filing |
| 2026-01-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 485 | $371.24 | $180,051.40 | filing |
| 2026-01-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 280 | $372.93 | $104,420.40 | filing |
| 2026-01-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 197 | $367.52 | $72,401.44 | filing |
| 2026-01-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 122 | $374.33 | $45,668.26 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 220 | $365.56 | $80,423.20 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 199 | $364.83 | $72,601.17 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 155 | $360.22 | $55,834.10 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 123 | $358.18 | $44,056.14 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 98 | $361.45 | $35,422.10 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 96 | $357.17 | $34,288.32 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 92 | $368.62 | $33,913.04 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 85 | $359.14 | $30,526.90 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 73 | $362.38 | $26,453.74 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 50 | $366.41 | $18,320.50 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 47 | $363.55 | $17,086.85 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 41 | $367.40 | $15,063.40 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 42 | $355.16 | $14,916.72 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 40 | $369.48 | $14,779.20 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 41 | $356.09 | $14,599.69 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 39 | $353.95 | $13,804.05 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 19 | $375.65 | $7,137.35 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 19 | $370.87 | $7,046.53 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 15 | $377.82 | $5,667.30 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 14 | $374.44 | $5,242.16 | filing |
| 2026-01-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 2 | $372.46 | $744.92 | filing |
| 2026-01-11 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 3,800 | $0.00 | $0.00 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 8,168 | $449.00 | $3.7M | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Option exercise | 8,161 | $119.13 | $972,219.93 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 794 | $458.41 | $363,977.54 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 707 | $460.84 | $325,813.88 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 622 | $459.89 | $286,051.58 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 368 | $455.24 | $167,528.32 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 364 | $456.25 | $166,075.00 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 323 | $461.96 | $149,213.08 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 295 | $463.08 | $136,608.60 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 262 | $457.39 | $119,836.18 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 129 | $451.51 | $58,244.79 | filing |
| 2025-11-17 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 96 | $450.09 | $43,208.64 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 555 | $452.69 | $251,242.95 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 449 | $450.81 | $202,413.69 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 276 | $451.86 | $124,713.36 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 273 | $453.77 | $123,879.21 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 207 | $449.79 | $93,106.53 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 203 | $454.84 | $92,332.52 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 150 | $448.77 | $67,315.50 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 122 | $457.43 | $55,806.46 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 96 | $446.53 | $42,866.88 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 60 | $455.82 | $27,349.20 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 47 | $447.92 | $21,052.24 | filing |
| 2025-10-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 3 | $457.64 | $1,372.92 | filing |
| 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 2,102 | $0.00 | $0.00 | filing |
| 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 2,851 | $0.00 | $0.00 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 543 | $454.04 | $246,543.72 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 329 | $452.96 | $149,023.84 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 241 | $454.84 | $109,616.44 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 103 | $451.99 | $46,554.97 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 90 | $449.92 | $40,492.80 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 39 | $450.92 | $17,585.88 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 39 | $447.98 | $17,471.22 | filing |
| 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Sale | 12 | $455.82 | $5,469.84 | filing |
| 2025-08-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 2,851 | $0.00 | $0.00 | filing |
| 2025-07-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Award | 7,763 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.